Determinants of health-related quality of life worsening in patients with chronic obstructive pulmonary disease at one year

Chinese Medical Journal

Volumn 127, Issue 1, 2014, Pages 4-10

  Liang, Li Rong ^a,b   Lin, Ying Xiang ^a,b   Yang, Ting ^a,b   Zhang, Hong ^a,b   Li, Jie ^a,b   Wang, Chen ^c  

^a Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Exacerbation; Health related quality of life; Risk factors

Indexed keywords

CORTICOSTEROID;

ADULT; ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DEPRESSION; DISEASE EXACERBATION; DYSPNEA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; QUALITY OF LIFE; RISK FACTOR; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; WALKING SPEED;

AGED; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS;

EID: 84891694781     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20131359     Document Type: Article

References (34)

1. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996; 51: 44-47.
2. Schrier AC, Dekker FW, Kaptein AA, Dijkman JH. Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice. Chest 1990; 98: 894-899.
3. Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD. Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest 2002; 122: 429-436.
4. Sprenkle MD, Niewoehner DE, Nelson DB, Nichol KL. The Veterans Short Form 36 questionnaire is predictive of mortality and health-care utilization in a population of veterans with a self-reported diagnosis of asthma or COPD. Chest 2004; 126: 81-89.
5. Curtis JR, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med 1997; 156: 1032-1039.
6. Curtis JR, Deyo RA, Hudson LD. Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994; 49: 162-170.
7. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56: 880-887.
8. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
9. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
10. Moy ML, Reilly JJ, Ries AL, Mosenifar Z, Kaplan RM, Lew R, et al. Multivariate models of determinants of health-related quality of life in severe chronic obstructive pulmonary disease. J Rehabil Res Dev 2009; 46: 643-654.
11. Felker B, Katon W, Hedrick SC, Rasmussen J, McKnight K, McDonnell MB, et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry 2001; 23: 56-61.
12. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med 2000; 94: 841-846.
13. Kaplan RM, Ries AL, Reilly J, Mohsenifar Z; National Emphysema Treatment Trial Research Group. Measurement of health-related quality of life in the national emphysema treatment trial. Chest 2004; 126: 781-789.
14. Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004; 59: 387-395.
15. Llor C, Molina J, Naberan K, Cots JM, Ros F, Miravitlles M. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare. Int J Clin Pract 2008; 62: 585-592.
16. Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, Espana PP, et al. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med 2009; 103: 1201-1208.
17. Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Wang C, et al. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Eur Respir J 2010; 35: 1022-1030.
18. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398-404.
19. Hajiro T, Nishimura K. Minimal clinically significant difference in health status: the thorny path of health status measures? Eur Respir J 2002; 19: 390-391.
20. Aaron SD, Vandemheen KL, Clinch JJ, Ahuja J, Brison RJ, Dickinson G, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest 2002; 121: 688-696.
21. Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Platt RW, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 2008; 178: 913-920.
22. Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Wang C, et al. Validation and clinical interpretation of the St George's Respiratory Questionnaire among COPD patients, China. Int J Tuberc Lung Dis 2009; 13: 181-189.
23. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
24. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
25. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580-586.
26. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
27. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
28. Lin YX, Xu WN, Liang LR, Pang BS, Nie XH, Zhang J, et al. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease. Chin Med J 2009; 122: 2939-2944.
29. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004; 23: 698-702.
30. Spencer S, Calverley PM, Sherwood BP, Jones PW. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 122-128.
31. Nannini LJ, Lasserson TJ, Poole P. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 9: CD006829.
32. Schlecht NF, Schwartzman K, Bourbeau J. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease. Chron Respir Dis 2005; 2: 183-191.
33. Redelmeier DA, Goldstein RS, Min ST, Hyland RH. Spirometry and dyspnea in patients with COPD: when small differences mean little. Chest 1996; 109: 1163-1168.
34. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-1289.